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ABSTRACT
Adducinsare afamilyofmembrane skeleton proteins
composed of a-, b- and g-subunits that promote actin
and spectrin association in erythrocytes. The a- and
g-subunits are expressed ubiquitously, while the
b-subunitisfoundinbrainanderythropoietictissues.
Thebrainb-adducinproteinissimilarinsizetothatof
spleen, but the mRNA transcript is a brain-specific
one that has not been yet characterized, having an
estimated length of 8–9 kb instead of the 3–4 kb of
spleen mRNA. Here, we show the molecular basis
for these differences by determining the structure
of the brain-specific b-adducin transcript in rats,
mice and humans. We identified a brain-specific pro-
moter in rodents that, apparently, was not conserved
in humans. In addition, we present evidence that the
brain-mRNAs are formed by a common mechanism
consisting in the tissue-specific use of alternative
polyadenylation sites generating unusually long 30-
untranslated region of up to 6.6 kb. This hypothesis
is supported by the presence of highly-conserved
regions flanking the brain-specific polyadenylation
site that suggest the involvement of these sequences
inthetranslationalregulation,stabilityand/orsubcel-
lular localization of the b-adducin transcript in the
brain.
INTRODUCTION
Adducins are a family of membrane skeleton proteins encoded
by three related genes (ADD1 or a, ADD2 or b and ADD3
or g). All three members undergo alternative splicing of their
pre-mRNA potentially generating a variety of protein iso-
forms, which have not yet been fully characterized (1–4).
Adducin is found as hetero-dimer or hetero-tetramer of a/b
or a/g composition in most tissues. Human erythrocytes exclu-
sively contain a/b heterodimers that promote the association
of actin and spectrin in the membrane skeleton (5). Both the a-
and g-adducin are expressed ubiquitously, while the b-adducin
gene shows a pattern of expression restricted to brain
and hematopoietic tissues such as bone marrow and spleen
(6–8), suggesting a different transcriptional regulation and
function for all three genes.
In the brain, a- and b-adducin expression is found to be
highly enriched in regions with high synapse densities of the
hippocampus, corpus striatum, cerebral cortex and cerebellum
(9,10), and it was shown recently that b-adducin may play a
role in the cellular processes underlying synaptic plasticity
associated with learning and memory (10). However, both
the gene structure of the b-adducin gene and the molecular
characterization of the mRNA isoforms are still incomplete.
In fact, the brain b-adducin gene product identiﬁed by
western blot analysis has roughly 110 kDa, only slightly
larger than that of 97 kDa detected in spleen (6,11), but the
b-adducin mRNA transcript that codes for this protein form is
a brain-speciﬁc one that has 8–9 kb instead of the 3–4 kb of
that one found in spleen (7,12). Although the long brain-
speciﬁc b-adducin mRNA has been described about 15
years ago (7,12), the molecular basis of this unusually long
brain-speciﬁc mRNA have not been characterized (1–3,13).
In the present work we determine the molecular structure of
the brain-speciﬁc b-adducin transcript in rat, mice and
humans. The b-adducin gene is found in chromosome 2, 6
and 4 in humans, mice and rats, respectively, in regions of
chromosomal synteny, suggesting a common evolution and
similar regulatory mechanisms in all three species. However,
the brain-speciﬁc promoter in rats and mice is not apparently
conserved in humans. We show the presence of an 8–9 kb long
b-adducin transcript also in human brains and we present
evidence of a common mechanism in all three species con-
sisting in the use of tissue-speciﬁc polyadenylation sites. In
addition, the regions ﬂanking the brain-speciﬁc polyadenyla-
tion site are highly conserved supporting the hypothesis of a
common mechanism regulating the 30-untranslated region
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doi:10.1093/nar/gkj425(30-UTR) in rats, mice and humans and highlighting the
importance of these sequences in the translational regulation,
stability and/or subcellular localization of the b-adducin tran-
script in brain.
MATERIALS AND METHODS
Animals
The generation of the mice devoid of b-adducin has been
described previously (6), the wild-type mice used were
C57BL/6. The rats were Sprague–Dawley. All animals used
in the experiments described below were males of 3 months of
age and were of nearly the same weight.
Protein preparation and western blot analysis
Protein preparations andwesternblot oferythrocytes andbrain
were as described (6).
RNA preparation, RT–PCR and northern blot analysis
Total cellular RNA was prepared basically by the guanidinium
thiocyanate method (14) from freshly extracted tissues from
rat and mice, quantiﬁed by measuring absorbance at 260 and
280 nm, and RNA integrity was conﬁrmed by running the
samples on 1% agarose formaldehyde gels. Human RNAs
werefromtwocommercial suppliers(Ambion andClonetech).
PCR primers used in the present work were prepared by Sigma
Genosis. Their sequence and speciﬁc use is detailed in Sup-
plementary Table 3. RT–PCRs were performed for 35 cycles.
For northern blot analysis, 20 mg of RNA was loaded in
1.2% agarose formaldehyde gels, transferred to nylon mem-
branes, and hybridized with the appropriate DNA probe
labeled with 32-aP-dCTP.
RNase protection and primer extension assays
For the RNase protection assay, overlapping fragments cov-
ering the entire rat b-adducin cDNA sequence were subcloned
from a full-length rat cDNA clone into pBS-KS plasmid. The
RNase protection assay was performed essentially as
described (15,16). Each of the DNA subclones was linearized,
the antisensestrand synthesized radioactivelywitheither T7or
T4 RNA polymerase and puriﬁed through denaturing acry-
lamide gels. The probe and b-adducin RNA hybrids were
digested, run in denaturing acrylamide gels and exposed for
autoradiography.
The primer extension assays were performed essentially as
described (15). Brieﬂy, the oligonucleotide 50bNC, comple-
mentary to the end of the 99 bases rat exon 2 was annealed to
rat spleen and brain RNA and the RT reaction was performed
in the presence of radioactive 32-aP-dCTP. The primer exten-
sion products were run in denaturing acrylamide gels and
exposed for autoradiography.
Database analyses and bioinformatics
The search for alternative exons in the b-adducin gene
required analysis of both cDNA and expressed sequence tag
(EST) sequences in the Genbank. To identify candidate ﬁrst
exons or alternative internal exons, we used each of the
b-adducin exon sequences as probes for BLAST species-
speciﬁc searches of Genbank. The candidate sequences that
were found contiguous to b-adducin exons were checked for
proper splicing and their chromosomal location was deter-
mined by BLAST analysis against the complete genome
using the NCBI browser (http://www.ncbi.nlm.nih.gov/
BLAST/). The alignment of the ESTs with the b-adducin
genomic sequence and the detection of the ESTs containing
poly(A) tails were analyzed manually with the help of the
UCSC Genome Browser (http://genome.ucsc.edu/). The coor-
dinates of the chromosomal position of the exons and introns
listed in Supplementary Table 1 refer to that used in the
ENSEMBL browser (July 2005) developed by the EMBL,
EBI and Sanger Institute (http://www.ensembl.org/index.
html). In order to conﬁrm experimentally that these sequences
were bona ﬁde exons in the b-adducin gene, RT–PCRs were
performed from brain and spleen total RNA and the results are
shown in Figure 3 and Supplementary Figure 2.
Promoter analysis was performed with both the DNAstar
Lasergene program and the TESS browser from the University
of Pennsylvania (http://www.cbil.upenn.edu/cgi-bin/tess/
tess?RQ¼WELCOME).Aselectionofthe predicted transcrip-
tion factor binding sites that displayed a high score and were
present in both analyses is shown in Supplementary Figure 1.
RESULTS
The reported full-length cDNAs for b-adducin (ADD2) in
mouse, rat and humans have 3119, 3115 and 3938 bp, respec-
tively and the molecular weight of the encoded proteins
[(6,7,12), ENSEMBL and Supplementary Table 1] is on
line with the presence of 50- and 30-UTR of average length
(17). In addition, the b-adducin pre-mRNA undergoes alter-
native splicing and northern blot analysis of erythropoietic
tissues using ab-adducin probe detectsthe expected b-adducin
bandsinthe range of3.5–4.5kbinallthreespecies (Figure1A,
Lanes 2, 4 and 7). In fact, more than one band was seen when
spleen RNA was used in the northern blot experiment and it
was suggested that they might be the result of alternative
splicing of the b-adducin pre-mRNA (1–3) generating the
b-add97 and b-add63 families of transcripts.
Interestingly, northern blot studies showed that the b-
adducin mRNA from brains of rats and mice had  8–9 kb
(Figure 1A, Lanes 1 and 3) while the protein band in the same
tissue had an apparent molecular weight of 110 kDa, only
slightly higher than that of 97 kDa observed in spleen
(Figure 1B, Lanes 8 and 9) (6,7,11,12). This is consistent
with previous reports that showed that brain adducin cross-
reacts immunologically with erythrocyte adducin having
at least 50% of antigenic sites in common (11). The size
differences between the brain and erythrocyte b-adducins
might be due to post-translational modiﬁcations, but, to our
knowledge, there is no report showing neither the reasons for
substantial differences between the mRNA and protein size
nor the complete identity of the erythroid and brain subunits.
In addition, we show in Figure 1A that the same size dif-
ference between brain and bone marrow mRNA was also
present in humans. In fact, an 8–9 kb band was also observed
by northern blot analysis of human brain RNA (Figure 1A,
Lane 5). It is interesting to note that the bands observed in
humans were slightly bigger than those of mice and rats.
Regrettably, we were not able to detect a clear signal of
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mercial suppliers (Figure 1A, lane 6), which might be due to
the fast degradation of the RNA in this tissue before sample
preparation. In fact, signiﬁcant RNA degradation was also
observed in human brain and bone marrow samples
(Figure 1A, lanes 5–7) and some of the observed bands
might be the result of alternative splicing and/or degradation
products.
Therefore, the brain b-adducin mRNA contains about 5–6
kb of extra sequences in all three species and, as mentioned
above, there is no report describing the molecular character-
ization of the brain b-adducin mRNA.
A brain-specific exon is present in the 50-UTR of
rats and mice
To identify the molecular basis of the size differences between
the brain and spleen b-adducin mRNAs we performed RT–
PCR analysis of brain and spleen RNA from mouse, rat and
human tissues. The PCRs covered the complete 50-UTR, cod-
ing regions and 30-UTR ofthe reported b-adducin sequences in
all three species, but produced in all cases the expected prod-
ucts and no extra band appeared that might explain the size
difference between brain and spleen b-adducin mRNAs (data
not shown).
To rule out that the ampliﬁcation of a putative longer PCR
product could be competed-out by the smaller expected
product, we performed RNase protection analysis of rat
brain and spleen total RNAs utilizing overlapping antisense
riboprobes encompassing the entire reported ADD2 cDNA
sequence. Again, no extra bands were observed when probes
corresponding to the coding exons were used, indicating the
absence of previously undetected exons inserted within the
reported b-adducin open reading frame (ORF) (data not
shown). In addition, this experiment demonstrated that the
ORFs of the erythrocyte and the brain subunits of b-adducin
were identical, providing supporting evidence that the size
differences between brain and erythrocyte b-adducin observed
in the western blot analysis are probably due to post-
translational modiﬁcations.
Surprisingly, when we used a probe covering the 50-UTR of
the reported rat b-adducin sequence we detected the expected
168 bases protected fragment for the spleen RNA (Figure 2A
and B, Lanes 2–3), but a smaller protected fragment of  100
bases was present in the brain RNA samples (Figure 2A and B,
Lanes 4–5). This indicated the presence of different 50-UTR in
b-adducin mRNAs from brain and spleen tissues.
The 50 RACE analysis of rat brain RNA led to the cloning
and sequencing of a brain-speciﬁc exon. The longest clone
contained a novel sequence of 258 bases (GenBank accession
no. DQ231568, Figure 3). RNase protection analysis using the
novel brain exon as probe produced the expected protected
fragmentof198basesinbrainRNAsamples(Figure2AandC,
Lanes 11–12) while a protected fragment of 104 bases was
observed in spleen RNA samples (Figure 2A and C, Lanes
9–10). This result conﬁrmed the exclusive presence of the
novel exon in brain b-adducin mRNAs and that of the previ-
ously reported 54 bp exon in spleen b-adducin mRNAs.
To determine the transcription initiation site of rat brain and
spleen b-adducin mRNAs we performed a primer extension
experiment utilizing a primer complementary to the 30 end of
the 99 bases exon, the ﬁrst exon common to brain and spleen
mRNAs (Figure 2D and the scheme of Supplementary
Figure 2A). Primer extension analysis of rat brain RNA
showed two main bands of about 300 and 320 bases, ending
very close to the 50 end of the longest cDNA clone obtained by
RACE–PCR of brain RNA (Figure 2D, Lanes 17–18). North-
ern blot analysis of RNA samples from mouse cerebellum,
brain and spleen with a probe speciﬁc for the brain exon is
shown in Figure 2E. A band of about 8–9 kb was observed in
cerebellum and brain RNA samples (Lanes 19–20) while no
band was observed for spleen RNA (Lane 21), conﬁrming the
tissue-speciﬁc expression of each exon as seen by the RNase
protectionexperiment and suggesting a link between the useof
the brain-speciﬁc promoter and the 8–9 kb long brain-speciﬁc
mRNA. In the analysis of the spleen RNA two main bands of
163 and 168 bases were observed by primer extension, the
bigger one coinciding with the reported transcription initiation
site of the rat b-adducin gene and smaller the one only 5 bases
downstream of that site (Figure 2D, Lanes 15–16, and
Supplementary Figure 1B).
Structure of brain and spleen-specific promoters
The 50 end of the human b-adducin mRNA has been deter-
mined by RACE analysis of RNA from a neuronal cell line
and, using the ampliﬁed product as probe, the genomic region
containing the putative human b-adducin promoter was cloned
(1). However, comparison of the b-adducin exonic architec-
ture and sequences among human, rat and mouse suggested
a different genomic structure for the 50 ends for the murine
b-adducin gene. While there was an almost perfect matching
Figure 1. Northern and western blot analysis of brain and spleen b-adducin.
(A) Northernblot analysisofmouse,rat andhumanRNAs. RNAs frommouse,
rat and human brain and spleen were loaded in lanes 1–6 (25 mg). In lane 7,
humanbonemarrowRNAswasloaded(25mg).AllRNAswereruninthesame
agarose formaldehyde gel, transferred to Hybond-N and hybridized with the
mouseandhumanb-adducinprobes(Lanes1–4and5–7,respectively).The28S
and18SrRNAsareindicated.(B)Brainandghostsproteinextracts(20mg)were
loadedina6%SDS–PAGE,blottedontonitrocellulose,incubatedwithananti-
b-adducin antibody and visualized by chemioluminiscence. MWMs are indi-
cated on the left. Br, brain; Sp, spleen; BM, bone marrow; Gh, ghosts.
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coding exons among the three species, the conservation and
length of the ﬁrst exon highly differed (Supplementary
Table 1). In fact, the human ﬁrst exon was 312 bp long,
while that of mice and rats had 219 bases. In addition, cloning
and sequencing of the putative rat brain promoter region
showed 90.8 and 94.1% of homology between mouse and
rat sequences for the promoter region (up to position  300
bp) and for the brain-speciﬁc exon, respectively (Supplemen-
tary Figure 1A and Supplementary Table 1). On the contrary,
the conservation between the human and rodent promoter
region and ﬁrst exons was only 47 and 53%, respectively.
Promoter prediction analysis of the human, rat and mouse
brain-speciﬁc promoters showed that the sequences 50 to the
mouse and rat brain-speciﬁc exons (mN1 and rN1 exons,
respectively) contained a consensus Inr sequence (18) and
several potential transcription binding sites (Supplementary
Figure 1A). The transcription site determined in rat by the
primer extension experiment exactly coincided with that
reported for the mouse b-adducin mRNA (ENSEMBL, tran-
script ENSMUST00000077101, Supplementary Figure 1A).
The in silico prediction showed that just a few transcription
factor sites were common among all three species and in the
human promoter numerous SP1 binding sites were predicted, a
transcription factor found in many housekeeping genes that
binds to GC rich regions, that were not so profuse in the rodent
promoter. In fact, the GC value of the human promoter was
79.3%whileintheratandmousebrainrodentpromotersitwas
of 55–60% supporting the observed differences in structure
and suggesting a diverse transcriptional regulation of this
b-adducin gene promoter.
Sequence comparison of the spleen-speciﬁc promoter
region and ﬁrst spleen-transcribed exon of rat and mouse
b-adducin erythroid-speciﬁc exons (mE1 and rE1, respec-
tively) with the recently reported human erythroid exon (hE1)
(13) showed 84% homology between rat and mouse, while the
homology between mE1 and rE1 sequences and the hE1 exon
were only of 43% and 47%, respectively (Supplementary
Figure 1B and Supplementary Table 1). Similarly to that
observed for the human erythroid promoter (13), both the
rat and mouse spleen promoters contained a conserved Inr
sequence (18). In addition, other potential transcription sites
Figure 2. Detection of brain- and spleen-specific b-adducin exons in rats and mice. (A) Schematic representation of the riboprobes used in the RNase protection
experimentshownin(BandC).Theinputprobeandthe sizeoftheprotectedfragmentsforeachprobeandeach tissueareindicated.(BandC)Thespleenandbrain
probesshownin(A)wereusedin(BandC),respectively.ThirtymicrogramsoftotalspleenandbrainRNAwereannealedtotheprobe,digestedwithRNase,runina
polyacrylamidedenaturinggelandautoradiographed.Lanes1and7correspondtotheundigestedprobe(inputprobe),lanes6and7areradioactivemolecularweight
markers,lanes2–3and9–10spleenRNA,andlanes4–5and11–12brainRNAs.Thearrowsindicatetheprotectedfragments.(D)Primerextensionexperimentwitha
primer annealing in the boundary between the constitutive 99 bp and the 217 bp exons (exons 2 and 3), that are present in both the brain and spleen forms of the
b-adducin mRNA. The arrows indicate the primer extension products observed in brain and spleen RNAs. Lanes 15–16 and 17–18 correspond to spleen and brain
RNAs, respectively. Lane 14 is a radioactive molecular weight marker, and lane 18 is a one-lane Sanger sequence using the same primer used in the experiment.
(E)Northernblotexperiment ofcerebellum,brainandspleenmouseRNA(lanes19–21,respectively)witha probecorrespondingtothe mousebrain-specific exon.
The position of the 28S and 18S rRNA is indicated.
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inSupplementaryFigure1B.Weobservedthatbetweenrodents
and humans most binding sites were not conserved. However,
those of the hematopoietic GATA transcription factor family
(19) predicted for the human erythroid E1 promoter (13) were
present in conserved regions of the rodent promoters.
Tissue-specificity of the b-adducin pre-mRNA
transcription
Anadditional functional difference betweenhuman and rodent
promoters is their tissue-speciﬁcity. In fact, while the mouse
and rat b-adducin pre-mRNAs are transcribed from a brain-
speciﬁc promoter, the human one seems to be active not only
in brain but also in spleen and bone marrow, and to a much
lesser extent in lung.
Weanalyzedthepatternofexpressionofthebrainandspleen-
speciﬁcexonsinkidney,liver,brain,lung,heart,placenta,bone
marrow and spleen of embryos, newborn and adult mice of
different ages. We observed that the mouse brain-speciﬁc pro-
moter was active in brain of 13.5 day-embryo, postnatal 1- and
14-day-old animals, and 3-month-old mice (Supplementary
Figure 2B, primers pair ‘a’). On the contrary, no expression
was observed in other tissues. The spleen promoter was active
in liver embryo and placenta, and had a low level of expression
in other embryonic tissues (Supplementary Figure 2B, primers
pair ‘c’). In 14-day-old mice and adults, the expression in the
liver and other tissues seemed to be completely shutdown and
was active only in the spleen and bone marrow.
To determine the expression pattern of the human exon 1we
used the same RNA samples with the pair of primers ‘a’ shown
in Figure 3B and Supplementary Table 3, that amplify the
fragment from human exon 1 to exon 3. A speciﬁc PCR prod-
uct was observed for brain, spleen, bone marrow and lung as
shown in Figure 3C (primers ‘a’), although the amount of RT–
PCR product observed in lung was very low. This experiment
strongly suggests differences in activity and tissue-speciﬁcity
between the rodent and human promoter. Those variations
might be related to the structural and base composition
changes observed among the species, as described above
and shown in Supplementary Figures 1 and 2.
The brain-specific b-adducin mRNA has an
unusually long 30-UTR
We showed above the existence of a novel brain-speciﬁc ﬁrst
exon and its putative promoter for rats and mice. However,
despite that this exon was longer than that used in spleen and
other organs, it did not account for the observed size differ-
ences between brain and spleen mRNAs (Figure 1 and Sup-
plementary Table 1). Therefore, we focused the search in the
30-UTR region to determine the molecular basis of the brain
8–9 kb b-adducin mRNA. Database search (UCSC Genome
Browser http://genome.ucsc.edu/) showed the presence of
ESTs transcripts in mouse, rat and humans in the region down-
stream to the known b-adducin 30-UTR, that in all three
cases have not been assigned as part of the b-adducin
mRNA. A scheme showing the alignment of the genomic
Figure3.Analysisofnewpotentialb-adducinexonsinhumans.(A)Schematicrepresentationofthehumanb-adducingenestructureshowingthepositionofthenew
potentialexonscomposedofnovelsequencesflankedbyknownb-adducinexons.Theopenboxesindicatetheexons1–17;theclosedboxesindicatethe112bpand
the143bpexons;andthedashedboxindicatestheerythroid-specificE1exon.(B)Schematicrepresentationshowsthepositionoftheoligonucleotidesutilizedinthe
RT–PCRtoamplifythe112bpexon(primerpairs‘b’and‘e’),the143bpexon(primerpairs‘c’and‘f’)andthe69bpexon(primerpairs‘d’and‘g’).Asnoproduct
wasobtainedafterthefirstroundofamplification(primerpairs‘b’,‘c’,‘d’,‘e’and‘f’),anestedPCRwasperformedwithnegativeresults(datanotshown).(C)The
primer pairs ‘a’ and ‘g’ showed in (B) that amplify a product from exon 1 to exon 3, and from exon E1 to exon 3, respectively, were utilized for an RT–PCR with
samples from brain, spleen (two independent preparations, lanes 1–2 and 4–5), bone marrow and lung.
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available mouse ESTs is shown in Figure 4A. Human and rat
EST distribution covered a similar region to that schematically
shown in Figure 4A for mice (data not shown).
To determine whether those ESTs could belong to the
b-adducin brain mRNA, a series of overlapping RT–PCR
analysis was performed using RNA from brain and spleen,
prepared from rat, mouse and human tissues. As schematically
shown in Figure 4A, the ﬁrst pair of primers (called ‘a’ in
Figure 4A and Supplementary Table 3) should amplify a por-
tion of the known b-adducin 30-UTR and up to 800–1100
bases, depending on the species, of the sequence downstream
of the reported 30-UTR of b-adducin. The other pairs of
primers (‘b’, ‘c’, ‘d’ and ‘e’, Figure 4A and Supplementary
Table 3) were complementary to sequences downstream to the
known b-adducin 30-UTR, and were designed in order that
each PCR product overlapped the ﬂanking ones covering
the entire region up to the most downstream EST shown in
Figure 4A.
The RT–PCR analysis showed speciﬁc PCR products in
brain samples for all primer pairs used (Figure 4B, Lanes 1,
6 and 11). In addition, an RT–PCR using a reverse primer
located 80 bases after the last reported EST and the forward
one used in pair ‘e’ produced no product, suggesting that all
the b-adducin brain mRNA ends at the same site (Figure 4A
and data not shown). These results strongly suggested that the
8–9 kb mRNA transcript observed in brain could be generated
by alternative usage of polyadenylation sites. To conﬁrm this
hypothesisweperformednorthernblotanalysisofmousebrain
and spleen RNAs from control and b-adducin KO mice using
two different probes of 600 and 800 bp that mapped down-
stream of the b-adducin stop codon present in exon 16, in the
novel 30-UTR of brain b-adducin mRNA (starting  1400 and
3500 bases downstream of the stop codon, respectively; see
scheme of Figure 4A). Both probes showed the presence of a
band of similar size to that detected for the mouse brain b-
adducin mRNA (Figure 4C, Lanes 1 and 5), conﬁrming that
the difference in size of the brain b-adducin mRNA is due to
the presence of an extremely long 30-UTR. In addition, taking
advantage of the b-adducin KO mice previously generated in
our laboratory (6), we run in the same gel RNA samples
prepared from the brain of KO mice and we also observed
Figure 4. The brain b-adducinmRNAhas an unusuallylong 30-UTR. (A) Schematicrepresentation corresponding to the mousegenomic region downstream of the
reportedpolyadenylationsite(UCSCbrowser).TheESTscorrespondingtothatregionareindicated.ThepositionofthePCRprimersusedtheRT–PCRsshownin(B)
are schematically indicated. The probesused in the northernblot experiment of (C)are shown.(B) RT–PCRsof brain andspleenRNA, from human(lanes 1–5),rat
(lanes 6–10)andmouse(lines11–15)tissueswere performedwithdifferent setof primersofthe regiondownstream ofthe reportedb-adducinpolyadenylationsite.
Lanes3–4,8–9and13–14wereperformedwiththesameRNAsoflanes1–2,6–7and11–12,respectively,butwithoutthereversetranscriptasereaction.Lanes5,10
and15correspondtothePCRwithouttheadditionofcDNA.(C)NorthernblotexperimentofbrainandspleentotalRNA(20mgperlane)fromcontrolandb-adducin
KO mice (control mice: lanes 1 and 5, brain; lanes 3 and 7, spleen; b-adducin KO mice: lanes 2 and 6, brain; lanes 4 and 8, spleen). Two identical membranes were
hybridizedwith30-UTRprobes1and2(Lanes1–4and5–6,respectively).Anarrowindicatesthedetectedbands.Thesizeofthebandobservedintheb-adducinKO
brain sample has a lower molecular weight due to the targeted deletion. The position of the 28S and 18S rRNA is indicated.
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indicating, unambiguously, that the detected band was indeed
the product of the b-adducin gene and not the result of unspe-
ciﬁc hybridization (Figure 4C, Lanes 2 and 6). The targeted
deletion in the b-adducin locus corresponds to a reduction of
744 bases in the b-adducin97 mRNA (exons 9 to 13) (6).
A faint band of similar size to that observed in brain RNA
samples of KO mice was also observed for spleen RNA sam-
ples of KO mice (Figure 4C, Lanes 4 and 8). These bands
could be the result of altered polyadenylation regulation in
spleen of the b-adducin deﬁcient mice due to the loss of
important regulatory sequences by the targeted genomic dele-
tion. In fact, no band is observed in the spleen RNA samples of
control mice (Figure 4, Lanes 3 and 7).
In addition, northern blot analysis using an Add63-speciﬁc
probe showed that the ADD63 family of transcripts also has a
long30-UTRinbrain(SupplementaryDataandSupplementary
Figure 3). Moreover, hybridization of a parallel membrane
with an Add97-speciﬁc probe suggested that the relative abun-
dance of the Add63 transcripts is considerably less than the
Add97 forms.
Ahighly-conservedbrain-specificpolyadenylationsiteis
used in mice, rats and humans
According to the scheme shown in Figure 4A, EST sequences
were aligned to genomic sequences of the region downstream
of the known b-adducin poly(A) site reported in the last exon
and were examined for the presence of poly(A) tails after
the alignment. Several EST-containing poly(A) tails were
found at chromosomal positions 86 554 176, 120 280 485
and 70 795 572 for mouse chromosome 6q, rat chromosome
4q and human chromosome 2p, respectively (see below and
Supplementary Tables 1 and 2), thus generating extremely
long brain-speciﬁc last exons of 6034, 5592 and 6951 bases
and a 30-UTR of 5831, 5289 and 6642 bases for mouse, rat and
human, respectively (Figure 5A and Supplementary Table 1).
We will call these distal brain-speciﬁc polyadenylation sites
mA4,r A 4 and hA4 for mice, rats and humans, respectively
(Figure 5A and C).
The DNA sequences of the last exon up to the detected
poly(A) sites, including the adjacent downstream regions,
were retrieved for all three species. Sequence comparison
among mouse, rat and human genomic sequences showed a
very high degree of conservation of the 30 end of the 8–9 kb
brain b-adducin transcript, specially in the region of the
polyadenylation site used in brain. In fact, within the 200 bp
region ﬂanking the distal brain polyadenylation signal we
observeda99.1%homologybetweenmouseandratsequences,
and a 75% homology among all three species (Figure 5C).
Analysis of the sequences lead us to the identiﬁcation in all
three species of all elements required for polyadenylation in
mammals: a polyadenylation signal, a putative poorly con-
served downstream elements (DSE) downstream of the
poly(A) site and a putative U-rich region (upstream element,
USE) located upstream of the polyadenylation motif
(Figure 5B and C). The polyadenylation motif AGTAAA
was found as the brain poly(A) signal in all three species.
A scheme of the last exon showing the relative position of
all the polyadenylation sites found in the last b-adducin exon
of all three species is shown in Figure 5A.
In addition, several ESTs containing poly(A) tails were
found for all three species, conﬁrming the use of these distal
polyadenylation sites (see the scheme of Figure 4A, Supple-
mentary Data and Supplementary Table 2). Other ESTs that
mapped nearby upstream to those mentioned above did not
contain the characteristic poly(A) tail. The observation that no
ESTs mapping downstream of the proposed polyadenylation
site were present (Figure 4A) together with the absence of an
RT–PCR product with primers at either side of the mA4
poly(A) site support the hypothesis that the brain b-adducin
pre-mRNA is completely polyadenylated at the proposed
A4 site.
Several proximal polyadenylation sites are present in
mice, rats and humans
Based on the available deposited sequences and ESTs, we
were able to identify two proximal polyadenylation regions
in rodents and three in humans that might generate the spleen
b-adducin mRNAs. The ﬁrst one was located between bases
1000 and 1150 relative to the start of the last exon (named
mA1,r A 1 and hA1, for mice, rats and humans, respectively,
see scheme of Figure 5A), should generate a 30-UTR of about
750–800 bases and showed a high conservation among the
three species (Figure 5A and Supplementary Figure 4). The
secondregion was betweenthe bases 1480–1640(having more
than one cleavage site) and coincided with the polyadenylation
region observed in humans at position 1600 relative to the start
of the last exon (named mA2-3,r A 2-3, and hA2 for mice, rats
and humans, respectively). The putative human polyadenyla-
tion signal of hA2 region was not conserved in rodents as they
bear a deletion of the region including that element. However,
ESTs with a variable position of the poly(A) tail were found in
the mA2-3 and rA2-3 regions (Supplementary Table 2) but
no consensus polyadenylation signal was identiﬁed in this
rodent region (Supplementary Figure 4B, underlined region).
Another polyadenylation site (hA3) mapping at position 2532
of the last human exon was detected and its functionality is
supported by the presence of numerous EST containing a
poly(A) tail (Figure 5A and Supplementary Table 2).
Additional supporting evidence derives from the observa-
tion that more than one band is present in the 3.5–4.5 kb region
in the northern blot shown in Figure 1A. In fact, we observe
two bands in rat and mouse spleen samples that might corre-
spond to the mRNA forms utilizing the A1 and A2-3
polyadenylation sites. In the human brain, we see three bands
that might be the results of the use of the hA1,h A 2 and hA3
polyadenylation sites (depicted in Figure 5A). In the bone
marrow sample we mainly detected the higher molecular
weight band, which might correspond to the use of the A3
polyadenylation site. The human bands were of higher
molecular weight than the rodent ones, which is on line with
the expected position of the different polyadenylation sites
and, in consequence, the length of the human transcripts
(Figures 1A and 5A). Alternatively, these bands might be
the consequence of the generation by alternative splicing of
the b-Add97 and b-Add63 families of transcripts. However,
this possibility is less probable as the Add63 levels are much
lower than those detected for the Add97 family of transcripts
(Supplementary Figure 3) and we have observed no other
major band in the RNase protection experiment of the
Nucleic Acids Research, 2006, Vol. 34, No. 1 249complete b-adducin ORF that might have been produced by
alternative splicing.
DISCUSSION
This report describes the complete primary structure of the
b-adducin mRNA of brain in humans, rats and mice. We show
that the brain mRNA form contains an unusually long 30-UTR
in all three species. Moreover, we present evidence that there
is a brain-speciﬁc promoter in rodents that was apparently not
conserved in humans. Consequently, the architecture of the
ADD2 gene is extremely complex with alternative use of
tissue-speciﬁc promoters and polyadenylation sites, in addi-
tion to the intricate alternative splicing pattern of the pre-
mRNA already described (2). Moreover, considering the
use of the brain-speciﬁc mN1 and rN1 exons, the maximum
predicted length of the primary transcript of the b-adducin
gene in brain was of 96 144 bases, 111 835 bases and 111
412 bases for mice, rats and humans, respectively. We also
provide evidence demonstrating the identity between the
ORFs of the brain and erythroid b-adducin subunits, suggest-
ing that the observed molecular weight differences in the
proteins are the result of post-translational modiﬁcations.
Genes encoding intracellular proteins tend to have alterna-
tive poly(A) sites (20) and many genes coding for proteins of
the membrane skeleton fall within this group having both
alternative promoters and polyadenylation sites. For example,
the ANK-1 gene has different polyadenylation sites and two
promoters thatdirect itsexpression toerythroid cells ormuscle
cells (21,22), protein 4.1 has three promoters that generate
distinct N-termini (23) and human band 7.2 gene also utilizes
alternative polyadenylation signals (24). In the case of ADD2,
we show here that there are two main distinct promoters in
rodents, one speciﬁc for hematopoietic tissues such as spleen
and bone marrow, and the other one speciﬁc for neuronal
tissues such as brain and cerebellum.
The observations that the homology between the human
promoter and rodent brain-speciﬁc promoter was only of
48% and that the structure and base composition were highly
different among species (80 and 55% of CG content for
humans and rodents, respectively) suggested important differ-
ences in the regulation of the brain-speciﬁc b-adducin tran-
script in humans and rodents. This hypothesis is supported by
the expression data of the human b-adducin gene promoter
(Figure 3). The presence of a human brain-speciﬁc promoter
was previously suggested [M. Bulger, unpublished data; (13)]
but we detected transcription from this promoter not only in
brain but also in hematopoietic tissues such as spleen and bone
Figure 5. Brain-specific alternative polyadenylationsites. (A) A schematic representation of the lastexon of the b-adducingene is shown.The ORF(graybox) and
thestopcodonareindicated.Thepositionsofthepolyadenylationsitesusedinbrainareindicated.The30-UTR(5731,5289and6642basesformice,ratsandhumans,
respectively)areindicatedasadottedbox.(B)Schematicrepresentationshowingthepositionoftheelementsfoundintheregionofthepolyadenylationsitesofgenes.
USE, upstream element; DSE, downstream element. (C) Sequence comparison among rats, mice and humans of the brain-specific polyadenylation sites. The
AGTAAAmotifsandthepolyadenylationsitesareunderlined.TheU-richandU/UG-richelementsareindicated.Numbersarerelativetothefirstbaseofthelastexon
of each species.
250 Nucleic Acids Research, 2006, Vol. 34, No. 1marrow, and at lower levels in lung (Figure 3). However, our
observations were performed by RT–PCR and need further
analysis for their conﬁrmation. The ubiquitous transcription
from the human promoter might be the consequence of the
presence of numerous binding sites of the transcription factor
SP1, which is required for ubiquitous transcription of multiple
housekeeping genes and play an important regulatory role in
cellular processes during development and differentiation
(25). On the contrary, the rodent brain-speciﬁc promoters
showed a very tight expression pattern, as we were able to
detect its activity only in mouse brain of 13.5 day embryo,
postnatal 1- and 14-day-old babies, and adults, but not in other
tissues, and no band corresponding to the product of this
promoter was detected in the rat spleen sample of the
RNase protection experiment. Therefore, we propose the des-
ignation of the rodent brain-speciﬁc promoters and ﬁrst exons
as mN1 and rN1, standing for neuronal mouse and rat ﬁrst
exons, respectively, but we suggest that the human promoter
and ﬁrst exon are not exclusive to brain (13).
Similarly to that observed in humans, [Figure 3C and (13)],
the activity of the mouse and rat spleen-speciﬁc promoter was
mainly detected in erythropoietic tissues such as liver embryos
and placenta, and was also active in other embryonic tissues,
although at a lower level of expression (Supplementary
Figure 2B, primers pair ‘c’). In 14-day-old mice, the expres-
sion in the liver and other tissues seemed to be completely
shutdown and was active only in the spleen and bone marrow.
Promoter comparison ofthe rodentspleen-speciﬁcpromoter
with the human E1 promoter (13) showed a 43 and 47%
homology with rats and mice, respectively, while the rat
and mouse sequences showed a higher homology (91%). Pre-
diction of the regulatory sites present in the rodent promoters
showed conservation of some of the sites but most of the
human-predictedones were not conserved. However, the bind-
ing sites of the hematopoietic GATA transcription factor fam-
ily (19) predicted for the human erythroid E1 promoter (13)
were present in conserved regions of the rodent promoters
suggesting that these erythroid promoters might be regulated,
at least in part, by mechanisms common to all three species.
Nevertheless,functional analyses are needed to more precisely
determine the in vivo regulation of both the brain- and spleen-
speciﬁc ADD2 promoters.
Despite the fact that the 8–9 kb ADD2 mRNA was detected
in brain about 15 years ago (7,12) and at least three attempts
that were made to completely characterize the ADD2 gene
structure (1,2,13), the molecular basis of this long brain-
speciﬁc form remained unknown. After ruling out the presence
of undetected internal exons or a long 50-UTR in the brain
isoform, we focused our attention to the 30-UTR. We detected
the presence of transcripts in the region downstream of the
reported ADD2 gene, and we demonstrated that they belong to
the brain-speciﬁc b-adducin mRNA, generating an 8262, 7817
and 9286 bases long mRNA for mice, rats and humans, respec-
tively. On the contrary, the longest form containing all internal
exons of the erythroid-speciﬁc transcript was 3664, 3574 and
4631 bases long for mice, rats and humans, respectively, when
the A3 polyadenylation site was used. The functionality of all
of the proposed polyadenylation sites is supported by the pres-
ence of several ESTs and mRNAs containing poly(A) tails.
We present evidence that the b-adducin pre-mRNA is pro-
cessed at many alternative polyadenylation sites, with the
more proximal ones mainly used in erythroid tissues and
the distal site in brain. In fact, in addition to the northern
blot data of brain RNA (Figure 4), almost all of the EST
and RNAs found in the databases that corresponded to the
distal A4 polyadenylation site were derived from brain or
brain-related tissues (Supplementary Table 2). On the con-
trary, libraries originated from a variety of tissues including
spleenandliverembryowere thesourceoftheRNAsequences
containing the other polyadenylation sites.
The UTRs of mRNAs regulate the expression of genes by
modifying the mRNA stability due to the presence of elements
affecting the degradation rate, the efﬁciency of transcription,
the translation efﬁciency by the presence of binding sites for
speciﬁc proteins and/or antisense RNAs, and the differential
concentration of the corresponding proteins in different sub-
cellular regions (26). It is striking the high degree of conser-
vation of the brain-speciﬁc polyadenylation region (A4) in all
three species studied. We observed a 99.1% homology
between mouse and rat sequences, and a 75% homology
among all three species, while the complete coding region
of b-adducin has 95.8% homology between rat and mouse
sequences, and 86.3% among all three species (6) and the
complete last exon showed 81 and 57% homology between
mice and rats, and rodents and humans, respectively (Supple-
mentary Table 1). Therefore, the highly-conserved polyadeny-
lation conﬁguration of mouse, rat and human b-adducin genes
highlights the importance of producing tissue-speciﬁc mRNA
products and suggests that the brain-speciﬁc 30-UTR could be
involved in the regulation of the function of the b-adducin
gene by one or more of the mechanisms mentioned above. The
AU-rich elements (AREs) are associated to the regulation of
mRNAstability and translation(17) and one ARE isfound 149
bases upstream of the brain-speciﬁc polyadenylation signal in
a highly-conserved region of all three species, suggesting that
it might play a regulatory role in the turnover and/or transla-
tion of the b-adducin mRNA in brain. However, the regulatory
role of the initiation step of translation by elements at the 30
end of eukaryotic mRNAs is still controversial (27,28).
Polyadenylation of the pre-mRNA is a process common to
the majority of genes transcribed by RNA polymerase II.
Three major steps in polyadenylation are (i) recognition of
the authentic poly(A) site; (ii) cleavage of the pre-mRNA; and
(iii) addition of up to 250 adenosine residues (29). The recog-
nition step is determined by at least two sequences: (i) the
polyadenylation signal (AAUAAA or similar) and (ii) the
U-rich or GU-rich elements found downstream of the cleavage
site. These two sequences are recognized by the cleavage and
polyadenylation factor (CPSF) and the cleavage stimulation
factor (CstF), respectively. CstF stimulates binding of CPSF to
non-AAUAAA sites conferring speciﬁcity to polyadenylation
site choice (30). In this respect, the poly(A) sites in mice, rats
and humans meet all these basic sequence requirements.
The most frequent poly(A) signal is AATAAA that is found
in 50–60% of genes (20,31,32), and polyadenylation signals
differing with the canonical sequence are usually associated
with alternative or tissue-speciﬁc polyadenylation (29).
AlthoughtheconsensussequenceforGU-andU-richelements
have been determined (29), some DSE contain no match to
either the U- or GU-rich consensus motifs and large deletions
are required to abolish its function. The USEs are often U-rich,
supporting the idea that those sites are poorly deﬁned and
Nucleic Acids Research, 2006, Vol. 34, No. 1 251possible redundant (29). The putative poly(A) signal for the
brain mRNA form was AGTAAA was fully conserved in all
three species and is found in about 3% of genes (20,31,32). In
the brain-speciﬁc A4 region, one polyadenylation site was
observed in rodents and two in humans (separated by only
5 bases), while multiple sites were found in each of the A1,A 2
and A3 regions in all three species. The reasons for the use of a
single poly(A) site in the A4 region could reside in presence of
a well-deﬁned and highly-conserved GU-rich element down-
stream of the brain-speciﬁc A4 poly(A) site. On the contrary,
the GU-rich element was poorly deﬁned in the proximal
polyadenylation regions (A1,A 2 and A3 regions). The associ-
ated elements (U- and GU-rich elements) found in distal brain
poly(A) region might be recognized by brain-speciﬁc CstF
and/or other tissue-speciﬁc factors favoring the binding of
CPSF, as observed with the tissue-speciﬁc tCstF-64 factor
found in germ cells (33), and prevailing over the use of the
proximal poly(A) sites. However, it is not clear how a distal
poly(A) site might inﬂuence the use of the upstream proximal
poly(A) site (30), but given the coupling between transcription
and pre-mRNA processing, it is conceivable that part of the
decision may occur at the promoter (29). Recent studies have
shown the coupling between the transcriptional processes and
pre-mRNA processing including pre-mRNA splicing and
polyadenylation (34–36). An intriguing possibility is that
the transcriptional complexes formed at the brain-speciﬁc pro-
moter could direct the polyadenylation machinery to the distal
polyadenylation sites, as already observed in the coupling of
transcription to pre-mRNA splicing (37,38).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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